Journal of Behavioral Medicine

, Volume 25, Issue 5, pp 487–497 | Cite as

The Prognosis After Multidisciplinary Treatment for Patients with Postinfectious Chronic Fatigue Syndrome and Noninfectious Chronic Fatigue Syndrome

  • Akinori Masuda
  • Takashi Nakayama
  • Takao Yamanaka
  • Yasuyuki Koga
  • Chuwa Tei

Abstract

The prognosis after multidisciplinary treatment for patients with postinfectious chronic fatigue syndrome (CFS, n = 9) and noninfectious CFS (n = 9) was clarified. After treatment, natural killer (NK) cell activity increased in the postinfectious CFS group but did not recover to within normal range in the noninfectious CFS group. In the postinfectious CFS group, physical and mental symptoms improved, and 8 patients returned to work. In the noninfectious CFS group, symptoms did not improve, and only 3 patients returned to work. The prognosis of postinfectious CFS group was better than that of noninfectious CFS group. Classification of CFS patients into postinfectious and noninfectious groups is useful for choosing the appropriate treatment in order to obtain better prognosis.

chronic fatigue syndrome prognosis multidisciplinary treatment cognitive–behavioral therapy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. Behan, P. O., Behan, W. M. H., and Horrobin, D. F. (1990). The use of essential fatty acids in chronic fatigue syndrome. Acta. Neurol. Scand. 82: 209–216.Google Scholar
  2. Butler, S., Chalder, T., Ron, M., and Wessely, S. (1991). Cognitive behaviour therapy in chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 54: 153–158.Google Scholar
  3. Cox, I. M., Campbell, M. J., and Dowson, D. (1991). Red blood cell magnesium and chronic fatigue syndrome. Lancet 337: 757–760.Google Scholar
  4. David, A. S. (1991). Postviral fatigue syndrome and psychiatry. Brit. Med. Bull. 47: 966–988.Google Scholar
  5. David, R. M. (1993). Pharmacological approaches to the therapy of chronic fatigue syndrome. Ciba Found. Sympo. 173: 280–287.Google Scholar
  6. Deale, A., Chalder, T., Marks, I., and Wessely, S. (1997). A randomised controlled trial of cognitive behavior versus relaxation therapy for chronic fatigue syndrome. Am. J. Psychiatry 154: 408–414.Google Scholar
  7. Fulcher, K. Y., and White, P. D. (1997). Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ 314: 1647–1652.Google Scholar
  8. Ganty, N. M., and Holmes, G. P. (1989). Treatment of patients with chronic fatigue syndrome. Drugs 38: 855–862.Google Scholar
  9. Goldenberg, D. L., Felson, D. T., and Dinerman, H. (1986). A randomized controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum. 29: 1371–1377. Prognosis After Treatment for Patients With CFS 497Google Scholar
  10. Hawton, K. E., Salkovskis, P. M., Kirk, J., and Clark, D. M. (1989). Cognitive Behaviour Therapy for Psychiatric Problems: A Practical Guide, Oxford Medical Publications, Oxford University Press, London.Google Scholar
  11. Hickie, I., Lloyd, A., Wakefield, D., and Parker, G. (1987). The psychiatric straus of patients with chronic fatigue syndrome. Br. J. Psychiatry 156: 534–540.Google Scholar
  12. Irwin, M., and Gillin, J.C. (1987). Impaired natural killer cell activity among depressive patients. Psychiatry Res. 20: 181–182.Google Scholar
  13. Levine, P. H. (1997). Epidemiologic advances in chronic fatigue syndrome. J. Psychiatr. Res. 31: 7–18.Google Scholar
  14. Masuda, A., Nozoe, S., Naruo, T., Soejima, Y., Nagai, N., Koga, Y., and Tanaka, H. (1995). Natural killer cell activity in relation to psychobehavioral responses, stress coping behavior, and fatigue in healthy adult men. Jpn. J. Psychosom. Med. 35: 383–390.Google Scholar
  15. O'Leary, A., Shoor, S., Lorig, K., and Holman, H. R. (1988). A cognitive‐behavioral treatment for rheumatoid arthritis. Health Psychol. 7: 527–544.Google Scholar
  16. Salit, I. E. (1997). Precipitating factors for the chronic fatigue syndrome. J. Psychiatr. Res. 31: 59–65.Google Scholar
  17. Schluenderberg, A., Straus, S. E., Peterson, P., Blumenthal, S., Komaroff, A. L., Spring, S. B., Landy, A., and Buchwald, D. (1992). Chronic fatigue syndrome research–Definition and medical outcome assessment. Ann. Intern. Med. 117: 325–331.Google Scholar
  18. Sharpe, M.C., Poveler, R., and Mayou, R. (1992). Psychological treatment of functional somatic symptoms: A practical guide. J. Psychosom. Res. 36: 515–527.Google Scholar
  19. Straus, S. E., Dale, J. K., Tobi, M., Lawley, T., Preble, O., Blaese, R. M., Hallahan, C., and Henle, W. (1988). Acyclovir treatment of the chronic fatigue syndrome: Lack of efficacy in a placebo-controlled trial. N. Engl. J. Med. 319: 1692–1698.Google Scholar
  20. Vercoulen, J., Swanink, C., Fennis, J., Galama, J., Meer, J., and Bleijenberg, G. (1996a). Prognosis in chronic fatigue syndrome: A prospective study on the natural course. J. Nuerol. Neurosurg. Psychiatry 60: 489–494.Google Scholar
  21. Vercoulen, J., Swanink, C., Zitman, F., Vreden, S., Hoofs, M., Fennis, J., Galama, J., Meer, J., and Bleijenberg, G. (1996b). Rondomized, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 347: 858–861.Google Scholar
  22. Wearden, A., Morriss, R., Mullis, R., Strickland, P. L., Pearson, D. J., Appleby, L., Campbell, I. T., and Morris, J. A. (1998). Rondomized, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br. J. Psychiatry 172: 485–490.Google Scholar
  23. Wilson, A., Hikie, I., Lloyd, A., and Wakefield, D. (1994). The treatment of chronic fatigue syndrome: Science and Speculation. Am. J. Med. 96: 544–550.Google Scholar

Copyright information

© Plenum Publishing Corporation 2002

Authors and Affiliations

  • Akinori Masuda
    • 1
  • Takashi Nakayama
    • 2
  • Takao Yamanaka
    • 3
  • Yasuyuki Koga
    • 4
  • Chuwa Tei
    • 1
  1. 1.First Department of Internal Medicine, Faculty of MedicineKagoshima UniversityKagoshimaJapan
  2. 2.The Department of Psychosomatic Medicine, Faculty of MedicineKagoshima University, KagoshimaJapan
  3. 3.National Institute of Fitness and SportsKanoyaJapan
  4. 4.Nishi Kyusyu UniversityJapan

Personalised recommendations